Year Founded
2024
Ownership
Private
Employees
~66
Stage
Preclinical
Modalities
Gene therapy

GEMMA Biotherapeutics General Information

Newly formed company focused on gene therapy research and development for rare diseases, launched in October 2024

Contact Information

Website
Primary Industry
Biotech
Corporate Office

Drug Pipeline

No pipeline data available

For full access to GEMMA Biotherapeutics's pipeline data

Book a demo

Key Partnerships

Fiocruz, Franklin Biolabs

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

GEMMA Biotherapeutics Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view GEMMA Biotherapeutics's complete valuation and funding history, request access »

GEMMA Biotherapeutics Investors

Double Point Ventures
Investor Type: Venture Capital
Holding: Minority
Bioluminescence Ventures
Investor Type: Venture Capital
Holding: Minority
Earlybird Venture Capital
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 4 investors. Get the full list »